Risks and management of hypertension in cancer patients undergoing targeted therapy: a review

BACKGROUND: Rapid progress over the last decade has added numerous agents targeting specific cellular signaling pathways to the treatment armamentarium for advanced cancer. However, many of these agents can cause hypertension resulting in major adverse cardiovascular event. METHODS AND RESULTS: A sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaolei, Wu, Shenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107678/
https://www.ncbi.nlm.nih.gov/pubmed/35568958
http://dx.doi.org/10.1186/s40885-022-00197-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107678/
https://www.ncbi.nlm.nih.gov/pubmed/35568958
http://dx.doi.org/10.1186/s40885-022-00197-3

Ejemplares similares